HomeMy WebLinkAbout2021_11_01 AHuenke_VaccinesFrom:Annette Huenke
To:jeffbocc
Cc:aberry@co.clallam.wa.us; Board of Health
Subject:as promised
Date:Monday, November 1, 2021 11:33:00 PM
ALERT:BE CAUTIOUS This email originated outside the organization. Do not open
attachments or click on links if you are not expecting them.
Commissioners et al…
Below is the link to the FDA fact sheet where you will find (page 14) reference to the
modified formulation of the product that is going to be injected into 5 to 11-year-olds. Pfizeris clearly anticipating clotting, stroke and cardiac adverse events, given the increases seen in
the 12 to 18-year-olds.
As I mentioned, historically a modification of this nature would have required a separateclinical trial (which would have taken years). This is a shocking dereliction of duty on the part
of the FDA and CDC, given the statistically-insignificant threat from SARS-CoV-2 to this agegroup.
https://www.fda.gov/media/153447/download
https://my.clevelandclinic.org/health/drugs/19820-tromethamine-solution-for-injection
The EUA requires informed consent. Will parents be asked if their child is taking any of the
medications that are contraindicated in conjunction with tromethamine? Will they be alerted
to the list of (at least) sixteen possible “mid-and long-term adverse effects from the
COVID-19 inoculants” referenced in the following toxicology report?
"Clinical trials for these inoculations were very short-term (a few months), had
samples not representative of the total population, and for adolescents/children, had
poor predictive power because of their small size. Further, the clinical trials did not
address changes in biomarkers that could serve as early warning indicators of
elevated predisposition to serious diseases. Most importantly, the clinical trials did
not address long-term effects that, if serious, would be borne by children/adolescents
for potentially decades.”
https://www.sciencedirect.com/science/article/pii/S221475002100161X
———————
According to Pfizer, the number of participants in the current clinical development program was“too small to detect any potential risks of myocarditis associated with vaccination.”
Long-term safety of Pfizer’s COVID-19 vaccine “to evaluate long-term sequelae of post-vaccination myocarditis/pericarditis” in participants 5 to <12 years of age will not be studied untilafter the vaccine is authorized for children,” Pfizer’s application noted.
https://informedchoicewa.org/covid-19/breaking-fda-panel-endorses-pfizer-shots-for-5-to-11-year-olds-experts-say-vaccine-
for-kids-is-unnecessary-premature-and-will-do-more-harm-than-good/
Think.
sincerely,Annette Huenke
PT